Pathology
 |
|
28 august 2018 05:00:07 |
| Safety of mogamulizumab for relapsed ATL after allogeneic hematopoietic cell transplantation (Bone Marrow Transplantation) |
|
Tweet |
| 135 viewsCategory: Medicine, Pathology |
 Health care utilization and cost among pediatric patients receiving unrelated donor allogeneic hematopoietic cell transplantation (Bone Marrow Transplantation)The 44th Annual Meeting of the European Society for Blood and Marrow Transplantation: QUALITY MANAGEMENT GROUP -- POSTER SESSION (Bone Marrow Transplantation) 
|
| blog comments powered by Disqus |
MyJournals.org
The latest issues of all your favorite science journals on one page
The latest issues of all your favorite science journals on one page
